Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis

Zhuang H et al (2001) Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42(9):1412–1417

Waki A, Fujibayashi Y, Yokoyama A (1998) Recent advances in the analyses of the characteristics of tumors on FDG uptake. Nucl Med Biol 25(7):589–592

Kubota K et al (2001) Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 28(6):696–703

Hustinx R et al (1999) Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 26(10):1345–1348

Gerbaudo VH et al (2003) Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax 58(12):1077–1082

Spence AM et al (2004) 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med 45(10):1653–1659

Ishizu K et al (1994) Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med 35(7):1104–1109

Delbeke D et al (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195(1):47–52

Britz-Cunningham SH, Millstine JW, Gerbaudo VH (2008) Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum. Clin Nucl Med 33(10):681–687

Chen W et al (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47(6):904–911

Gonzalez J et al (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67(2):323–326

Arnold SM, Patchell RA (2001) Diagnosis and management of brain metastases. Hematol Oncol Clin North Am 15(6):1085–1107

Hustinx R et al (2005) PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am 43(1):35–47

Langleben DD, Segall GM (2000) PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41(11):1861–1867

Patronas NJ et al (1982) Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144(4):885–889

Gambhir SS et al (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42(5 Suppl):1S–93S

Mogard J et al (1994) Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG. J Comput Assist Tomogr 18(2):177–181

Ricci PE et al (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19(3):407–413

Chen W et al (2005) Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med 46(6):945–952

Kang TW et al (2009) Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 72(3):370–380

Sokoloff L et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28(5):897–916

Spence AM et al (2004) 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med 45(10):1653–1659

Bissonnette P et al (1996) 2-Deoxyglucose transport and metabolism in Caco-2 cells. Am J Physiol 270(1 Pt 1):G153–G162

Higashi T et al (2002) Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43(2):173–180

Lodge MA et al (1999) A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 26(1):22–30

Yamada S et al (1995) High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36(7):1301–1306

Hamberg LM et al (1994) The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 35(8):1308–1312

Zhao (2003) Delayed 18F-FDG PET brain imaging improves detection rate of brain metastases. In: Proceedings of the SNM 50th annual meeting, vol 44(5), p 243P